| Year |
Citation |
Score |
| 2023 |
Tong Y, Tonui P, Orang'o O, Zhang J, Maina T, Muthoka K, Groopman J, Smith J, Madeen E, Ermel A, Loehrer P, Brown DR. Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study. Bmc Infectious Diseases. 23: 377. PMID 37280534 DOI: 10.1186/s12879-023-08323-8 |
0.571 |
|
| 2023 |
Tong Y, Tonui P, Orang'o O, Zhang J, Maina T, Muthoka K, Groopman J, Smith J, Madeen E, Ermel A, Loehrer P, Brown D. Association of Plasma Aflatoxin With Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples From Kenyan Women Enrolled in a Longitudinal Study. Research Square. PMID 36747756 DOI: 10.21203/rs.3.rs-2468599/v1 |
0.58 |
|
| 2022 |
Orang'o O, Tonui P, Muthoka K, Kiptoo S, Maina T, Agosa M, Ermel A, Tong Y, Brown D. A community-based approach to cervical cancer prevention in western Kenya: An AMPATH feasibility project. Sage Open Medicine. 10: 20503121221102111. PMID 35646368 DOI: 10.1177/20503121221102111 |
0.428 |
|
| 2022 |
Brown DR, Castellsagué X, Ferris D, Garland SM, Huh W, Steben M, Wheeler CM, Saah A, Luxembourg A, Li S, Velicer C. Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women. Tumour Virus Research. 200236. PMID 35525430 DOI: 10.1016/j.tvr.2022.200236 |
0.521 |
|
| 2021 |
Ermel A, Tong Y, Tonui P, Orang'o O, Muthoka K, Wong N, Manai T, Kiptoo S, Loehrer PJ, Brown DR. Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV. International Journal of Std & Aids. 9564624211030766. PMID 34233531 DOI: 10.1177/09564624211030766 |
0.334 |
|
| 2021 |
Sauter SL, Zhang X, Romick-Rosendale L, Wells SI, Myers KC, Brusadelli MG, Poff CB, Brown DR, Panicker G, Unger ER, Mehta PA, Bleesing J, Davies SM, Butsch Kovacic M. Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia. Cancers. 13. PMID 33803570 DOI: 10.3390/cancers13061368 |
0.573 |
|
| 2021 |
Brown DR, Joura EA, Yen GP, Kothari S, Luxembourg A, Saah A, Walia A, Perez G, Khoury H, Badgley D, Stanley M. Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence. Vaccine. PMID 33744051 DOI: 10.1016/j.vaccine.2020.11.076 |
0.486 |
|
| 2021 |
Stanley M, Joura E, Yen GP, Kothari S, Luxembourg A, Saah A, Walia A, Perez G, Khoury H, Badgley D, Brown DR. Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines. Vaccine. PMID 33658126 DOI: 10.1016/j.vaccine.2021.01.060 |
0.472 |
|
| 2020 |
Tong Y, Tonui P, Ermel A, Orang'o O, Wong N, Titus M, Kiptoo S, Muthoka K, Loehrer PJ, Brown DR. Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women. Sage Open Medicine. 8: 2050312120945138. PMID 32782796 DOI: 10.1177/2050312120945138 |
0.421 |
|
| 2020 |
Orang'o EO, Emont JP, Ermel AC, Liu T, Omodi V, Tong Y, Itsura PM, Tonui PK, Maina T, Ong'echa JM, Muthoka K, Kiptoo S, Moormann A, Hogan J, Loehrer PJ, ... Brown D, et al. Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 32715467 DOI: 10.1002/Ijgo.13330 |
0.49 |
|
| 2020 |
Ferris DG, Brown D, Giuliano AR, Myers E, Joura EA, Garland SM, Kjaer SK, Perez G, Saah A, Luxembourg A, Velicer C. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial. Papillomavirus Research (Amsterdam, Netherlands). 100202. PMID 32464334 DOI: 10.1016/J.Pvr.2020.100202 |
0.623 |
|
| 2020 |
Covert C, Kahn J, Ding L, Franco E, Brown D, Ermel A. 68. HPV Vaccine Effectiveness with Different Dosing Schedules in a Community Setting Journal of Adolescent Health. 66: S35-S36. DOI: 10.1016/J.Jadohealth.2019.11.071 |
0.533 |
|
| 2019 |
Widdice LE, Bernstein DI, Franco EL, Ding L, Brown DR, Ermel AC, Higgins L, Kahn JA. Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction. Vaccine. PMID 31582269 DOI: 10.1016/J.Vaccine.2019.08.052 |
0.536 |
|
| 2019 |
Mburu A, Itsura P, Mabeya H, Kaaria A, Brown DR. Knowledge of Cervical Cancer and Acceptability of Prevention Strategies Among Human Papillomavirus-Vaccinated and Human Papillomavirus-Unvaccinated Adolescent Women in Eldoret, Kenya. Bioresearch Open Access. 8: 139-145. PMID 31475078 DOI: 10.1089/Biores.2019.0007 |
0.53 |
|
| 2019 |
Zhang J, Orang'o O, Tonui P, Tong Y, Maina T, Kiptoo S, Muthoka K, Groopman J, Smith J, Madeen E, Ermel A, Loehrer P, Brown DR. Detection and Concentration of Plasma Aflatoxin is Associated with Detection of Oncogenic Human Papillomavirus in Kenyan Women. Open Forum Infectious Diseases. PMID 31392332 DOI: 10.1093/Ofid/Ofz354 |
0.586 |
|
| 2019 |
Ermel A, Tonui P, Titus M, Tong Y, Wong N, Ong'echa J, Muthoka K, Kiptoo S, Moormann A, Hogan J, Mwangi A, Cu-Uvin S, Loehrer PJ, Orang'o O, Brown D. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women. Bmc Infectious Diseases. 19: 352. PMID 31029097 DOI: 10.1186/S12879-019-3982-7 |
0.619 |
|
| 2019 |
Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA. Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Pediatrics. PMID 30670582 DOI: 10.1542/peds.2018-1902 |
0.47 |
|
| 2019 |
Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Human Vaccines & Immunotherapeutics. PMID 30633598 DOI: 10.1080/21645515.2018.1564438 |
0.595 |
|
| 2019 |
Omenge E, Tong Y, Tonui P, Ong’echa JM, Muthoka K, Kiptoo S, Maina T, Itsura P, Moormann A, Wong Y, Ermel A, Liu T, Hogan J, Loehrer PJ, Brown D, et al. Comparison of HPV detection in HIV-infected and HIV-uninfected Kenyan women with or without cervical dysplasia. Journal of Clinical Oncology. 37: e17015-e17015. DOI: 10.1200/Jco.2019.37.15_Suppl.E17015 |
0.577 |
|
| 2019 |
Zhiang J, Omenge E, Maina T, Muthoka K, Kiptoo S, Groopman J, Tong Y, Ermel A, Loehrer PJ, Brown D. Association of detection of aflatoxin in plasma of Kenyan women with increased detection of oncogenic HPV. Journal of Clinical Oncology. 37: 5530-5530. DOI: 10.1200/Jco.2019.37.15_Suppl.5530 |
0.624 |
|
| 2018 |
Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, et al. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age. Obstetrics and Gynecology. PMID 29995724 DOI: 10.1097/Aog.0000000000002736 |
0.433 |
|
| 2018 |
Ermel A, Shew ML, Imburgia TM, Brown M, Qadadri B, Tong Y, Brown DR. Redetection of Human Papillomavirus Type 16 Infections of the Cervix in Mid-Adult Life. Papillomavirus Research (Amsterdam, Netherlands). PMID 29355777 DOI: 10.1016/J.Pvr.2018.01.001 |
0.576 |
|
| 2018 |
Brown DR, Maina T, Tonui P, Ong’echa JM, Ermel A, Muthoka K, Kiptoo S, Tong Y, Wong Y, Moormann A, Mwangi A, Hogan J, Loehrer PJ, Omenge E. AMPATH Oncology: Baseline HPV detection in Kenyan women enrolled in a longitudinal study of modifiable factors predicting cervical dysplasia. Journal of Clinical Oncology. 36: 5533-5533. DOI: 10.1200/Jco.2018.36.15_Suppl.5533 |
0.633 |
|
| 2018 |
Spinner C, Ding L, Bernstein D, Brown DR, Franco EL, Kahn JA. 9-Valent and 4-Valent HPV Vaccine Effectiveness and Herd Protection among Young Women, 11 Years after Vaccine Introduction Journal of Adolescent Health. 62. DOI: 10.1016/J.Jadohealth.2017.11.172 |
0.523 |
|
| 2017 |
Saccucci M, Franco EL, Ding L, Bernstein DI, Brown D, Kahn JA. Non-Vaccine-Type HPV Prevalence after Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection. Sexually Transmitted Diseases. PMID 29465705 DOI: 10.1097/Olq.0000000000000731 |
0.546 |
|
| 2017 |
Saccucci M, Ding L, Franco E, Bernstein DI, Brown D, Kahn JA. Epidemiologic Trends in Non-Vaccine-Type HPV After Vaccine Introduction: No Evidence For Type Replacement but Evidence for Cross-Protection Journal of Adolescent Health. 60. DOI: 10.1016/J.Jadohealth.2016.10.056 |
0.525 |
|
| 2016 |
Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, et al. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region. Papillomavirus Research (Amsterdam, Netherlands). 2: 61-69. PMID 29074187 DOI: 10.1016/J.Pvr.2016.03.002 |
0.589 |
|
| 2016 |
Ermel A, Qadadri B, Tong Y, Orang'o O, Macharia B, Ramogola-Masire D, Zetola NM, Brown DR. Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications. Infectious Agents and Cancer. 11: 56. PMID 27843487 DOI: 10.1186/S13027-016-0102-9 |
0.658 |
|
| 2016 |
Kahn JA, Widdice LE, Ding L, Huang B, Brown DR, Franco EL, Bernstein DI. Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27655996 DOI: 10.1093/Cid/Ciw533 |
0.6 |
|
| 2016 |
Garland SM, Kjaer SK, Muñoz N, Block SL, Brown DR, DiNubile MJ, Lindsay BR, Kuter BJ, Perez G, Dominiak-Felden G, Saah AJ, Drury R, Das R, Velicer C. Impact and Effectiveness Of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of Ten Years of Real-World Experience. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27230391 DOI: 10.1093/Cid/Ciw354 |
0.619 |
|
| 2016 |
Brown D, Kulkarni AS, Pillsbury M, Saah A, Luxembourg A. Clarification on the Impact of Cervarix Vaccination on Human Papillomavirus Infection and Cervical Cancer in the United Kingdom. Human Vaccines & Immunotherapeutics. 0. PMID 26857560 DOI: 10.1080/21645515.2016.1143159 |
0.518 |
|
| 2016 |
Chandler EL, Ding L, Widdice L, Thomas R, Bernstein DI, Brown DR, Franco EL, Kahn JA. Epidemiology of Anogenital Human Papillomavirus (HPV) Among 13-26 Year-Old Young Men after HPV Vaccine Introduction Journal of Adolescent Health. 58. DOI: 10.1016/J.Jadohealth.2015.10.245 |
0.648 |
|
| 2016 |
Widdice LE, Ding L, Bernstein DI, Brown DR, Franco EL, Huang B, Kahn JA. Epidemiologic Impact of HPV Vaccination and Evidence for Herd Immunity Over the First 8 Years after Vaccine Introduction in a Community Journal of Adolescent Health. 58. DOI: 10.1016/J.Jadohealth.2015.10.033 |
0.499 |
|
| 2015 |
Shew ML, Ermel AC, Tong Y, Tu W, Qadadri B, Brown DR. Episodic detection of human papillomavirus within a longitudinal cohort of young women. Journal of Medical Virology. PMID 26112742 DOI: 10.1002/Jmv.24284 |
0.653 |
|
| 2015 |
Luxembourg A, Brown D, Bouchard C, Giuliano AR, Iversen OE, Joura EA, Penny ME, Restrepo JA, Romaguera J, Maansson R, Moeller E, Ritter M, Chen J. Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine. Human Vaccines & Immunotherapeutics. 11: 1313-22. PMID 25912208 DOI: 10.1080/21645515.2015.1012010 |
0.551 |
|
| 2015 |
Sauter SL, Wells SI, Zhang X, Hoskins EE, Davies SM, Myers KC, Mueller R, Panicker G, Unger ER, Sivaprasad U, Brown DR, Mehta PA, Butsch Kovacic M. Oral human papillomavirus is common in individuals with Fanconi anemia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 864-72. PMID 25809863 DOI: 10.1158/1055-9965.Epi-15-0097-T |
0.447 |
|
| 2015 |
Kahn JA, Whittemore D, Ding L, Widdice L, Brown D, Bernstein D, Kahn J. 156. Detection of HPV 16/18 Does not Differ By Race or Ethnicity in Young Women Journal of Adolescent Health. 56. DOI: 10.1016/J.Jadohealth.2014.10.160 |
0.582 |
|
| 2014 |
Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1997-2008. PMID 25274978 DOI: 10.1158/1055-9965.Epi-14-0410 |
0.64 |
|
| 2014 |
Brown D, Müller M, Sehr P, Pawlita M, Seitz H, Rubio I, Antonello J, Radley D, Roberts C, Saah A. Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18. Vaccine. 32: 5880-7. PMID 25148777 DOI: 10.1016/J.Vaccine.2014.08.004 |
0.622 |
|
| 2014 |
Ermel A, Ramogola-Masire D, Zetola N, Tong Y, Qadadri B, Azar MM, Brown DR. Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution. Infectious Agents and Cancer. 9: 22. PMID 25053972 DOI: 10.1186/1750-9378-9-22 |
0.409 |
|
| 2014 |
Garland SM, Brown DR. Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer. Expert Opinion On Biological Therapy. 14: 527-34. PMID 24472154 DOI: 10.1517/14712598.2014.880418 |
0.602 |
|
| 2014 |
Ermel AC, Shew ML, Weaver BA, Qadadri B, Denski C, Tu W, Tong Y, Fortenberry JD, Brown DR. DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women. Sexually Transmitted Infections. 90: 64-9. PMID 24031030 DOI: 10.1136/Sextrans-2012-050886 |
0.599 |
|
| 2013 |
Shew ML, Ermel AC, Weaver BA, Tong Y, Tu W, Kester LM, Denski C, Fortenberry JD, Brown DR. Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. The Journal of Infectious Diseases. 208: 1416-21. PMID 23911713 DOI: 10.1093/Infdis/Jit346 |
0.647 |
|
| 2013 |
Tong Y, Ermel A, Tu W, Shew M, Brown DR. Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women. Journal of Medical Virology. 85: 1786-93. PMID 23861239 DOI: 10.1002/Jmv.23664 |
0.633 |
|
| 2013 |
Brown DR, Weaver B. Human papillomavirus in older women: new infection or reactivation? The Journal of Infectious Diseases. 207: 211-2. PMID 23242539 DOI: 10.1093/Infdis/Jis662 |
0.663 |
|
| 2013 |
Shew ML, Weaver B, Tu W, Tong Y, Fortenberry JD, Brown DR. High frequency of human papillomavirus detection in the vagina before first vaginal intercourse among females enrolled in a longitudinal cohort study. The Journal of Infectious Diseases. 207: 1012-5. PMID 23242538 DOI: 10.1093/Infdis/Jis775 |
0.622 |
|
| 2012 |
Widdice LE, Brown DR, Bernstein DI, Ding L, Patel D, Shew M, Fortenberry JD, Kahn JA. Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose. Archives of Pediatrics & Adolescent Medicine. 166: 774-6. PMID 22869412 DOI: 10.1001/Archpediatrics.2012.586 |
0.623 |
|
| 2012 |
Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, Bernstein DI. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics. 130: e249-56. PMID 22778297 DOI: 10.1542/Peds.2011-3587 |
0.63 |
|
| 2012 |
Cummings T, Zimet GD, Brown D, Tu W, Yang Z, Fortenberry JD, Shew ML. Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine. 30: 5496-9. PMID 22750043 DOI: 10.1016/J.Vaccine.2012.06.057 |
0.649 |
|
| 2012 |
Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, Lambert PF, Brown DR, Gillison ML, Nuovo GJ, Witte DP, Kim MO, Davies SM, Mehta PA, Butsch Kovacic M, Wikenheiser-Brokamp KA, et al. The fanconi anemia pathway limits human papillomavirus replication. Journal of Virology. 86: 8131-8. PMID 22623785 DOI: 10.1128/Jvi.00408-12 |
0.564 |
|
| 2012 |
Wiley DJ, Masongsong EV, Lu S, Heather L S, Salem B, Giuliano AR, Ault KA, Haupt RM, Brown DR. Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections. Cancer Epidemiology. 36: e183-9. PMID 22277329 DOI: 10.1016/J.Canep.2011.12.007 |
0.517 |
|
| 2012 |
Kester LM, Shew M, Fortenberry JD, Tu W, Tong Y, Ermel AC, Brown DR. 6. Reconsidering the Framing of Clinical Messages to Patients Concerning HPV: Further Evaluation of the Natural History of HPV Infection Journal of Adolescent Health. 50: S9. DOI: 10.1016/J.Jadohealth.2011.10.037 |
0.633 |
|
| 2011 |
Joshi H, Cheluvaraja S, Somogyi E, Brown DR, Ortoleva P. A molecular dynamics study of loop fluctuation in human papillomavirus type 16 virus-like particles: a possible indicator of immunogenicity. Vaccine. 29: 9423-30. PMID 22027487 DOI: 10.1016/J.Vaccine.2011.10.039 |
0.495 |
|
| 2011 |
Weaver B, Shew M, Qadadri B, Tu W, Tong Y, Denski C, Fortenberry JD, Ermel A, Brown D. Low-level persistence of human papillomavirus 16 DNA in a cohort of closely followed adolescent women. Journal of Medical Virology. 83: 1362-9. PMID 21678439 DOI: 10.1002/Jmv.22116 |
0.659 |
|
| 2011 |
Weaver B, Shew M, Qadadri B, Tu W, Tong Y, Denski C, Fortenberry JD, Brown D. Natural history of multiple human papillomavirus infections in female adolescents with prolonged follow-up. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 48: 473-80. PMID 21501806 DOI: 10.1016/J.Jadohealth.2010.08.003 |
0.646 |
|
| 2011 |
Haupt RM, Wheeler CM, Brown DR, Garland SM, Ferris DG, Paavonen JA, Lehtinen MO, Steben M, Joura EA, Giacoletti KE, Radley DR, James MK, Saah AJ, Sings HL. Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. International Journal of Cancer. Journal International Du Cancer. 129: 2632-42. PMID 21491420 DOI: 10.1002/Ijc.25940 |
0.64 |
|
| 2011 |
Ault KA, Brown DR. Advancing human papillomavirus research with a rhesus monkey model. Journal of the National Cancer Institute. 103: 703. PMID 21483022 DOI: 10.1093/Jnci/Djr125 |
0.337 |
|
| 2011 |
Brown DR, Garland SM, Ferris DG, Joura E, Steben M, James M, Radley D, Vuocolo S, Garner EI, Haupt RM, Bryan JT. The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay. Human Vaccines. 7: 230-8. PMID 21307649 DOI: 10.4161/Hv.7.2.13948 |
0.576 |
|
| 2011 |
Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Hernandez-Avila M, Brown DR, Elbasha E, Muñoz N, Paavonen J, Haupt RM, et al. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 287-96. PMID 21300618 DOI: 10.1158/1055-9965.Epi-10-0791 |
0.556 |
|
| 2011 |
Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, et al. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. International Journal of Cancer. Journal International Du Cancer. 128: 1344-53. PMID 20949623 DOI: 10.1002/Ijc.25723 |
0.636 |
|
| 2011 |
Weaver BA, Brown D, Fortenberry JD. S14.1 Genital and oral human papillomavirus in adolescent males Sexually Transmitted Infections. 87. DOI: 10.1136/Sextrans-2011-050102.56 |
0.601 |
|
| 2011 |
Weaver B, Tu W, Shew M, Qadadri B, Tong Y, Denski C, Fortenberry JD, Brown D. 2. Acquisition of First Human Papillomavirus Infection Related to First Vaginal Intercourse and Other Sexually Transmitted Infections in Adolescent Women Journal of Adolescent Health. 48: S11-S12. DOI: 10.1016/J.Jadohealth.2010.11.031 |
0.388 |
|
| 2011 |
Widdice L, Brown D, Bernstein D, Ding L, Patel D, Shew M, Fortenberry JD, Jessica K. 3. Prevalence of HPV in Sexually Experienced and Inexperienced Females Initiating HPV Vaccination Journal of Adolescent Health. 48. DOI: 10.1016/J.Jadohealth.2010.11.011 |
0.346 |
|
| 2010 |
Ermel A, Qadadri B, Morishita A, Miyagawa I, Yamazaki G, Weaver B, Tu W, Tong Y, Randolph M, Cramer H, Brown D. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay. Journal of Virological Methods. 169: 154-61. PMID 20670658 DOI: 10.1016/J.Jviromet.2010.07.016 |
0.637 |
|
| 2010 |
Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. Bmj (Clinical Research Ed.). 341: c3493. PMID 20647284 DOI: 10.1136/Bmj.C3493 |
0.613 |
|
| 2010 |
Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Brown DR, Elbasha EH, Paavonen J, Haupt RM. Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1585-94. PMID 20530494 DOI: 10.1158/1055-9965.Epi-09-1235 |
0.535 |
|
| 2010 |
Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Journal of the National Cancer Institute. 102: 325-39. PMID 20139221 DOI: 10.1093/Jnci/Djp534 |
0.664 |
|
| 2010 |
Block SL, Brown DR, Chatterjee A, Gold MA, Sings HL, Meibohm A, Dana A, Haupt RM, Barr E, Tamms GM, Zhou H, Reisinger KS. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine. The Pediatric Infectious Disease Journal. 29: 95-101. PMID 19952863 DOI: 10.1097/Inf.0B013E3181B77906 |
0.474 |
|
| 2010 |
Weaver B, Shew M, Qadadri B, Tu W, Tong Y, Denski C, Fortenberry JD, Brown D. Ubiquity of HPV Infection in Adolescent Women with Extended Follow-UP Journal of Adolescent Health. 46: S28. DOI: 10.1016/J.Jadohealth.2009.11.067 |
0.577 |
|
| 2009 |
Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Tang GW, et al. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Human Vaccines. 5: 696-704. PMID 19855170 DOI: 10.4161/Hv.5.10.9515 |
0.566 |
|
| 2009 |
Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prevention Research (Philadelphia, Pa.). 2: 868-78. PMID 19789295 DOI: 10.1158/1940-6207.Capr-09-0031 |
0.531 |
|
| 2009 |
Brown CR, Leon ML, Muñoz K, Fagioni A, Amador LG, Frain B, Tu W, Qadadri B, Brown DR. Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De BiofãSica ... [Et Al.]. 42: 629-36. PMID 19578642 DOI: 10.1590/S0100-879X2009000700007 |
0.654 |
|
| 2009 |
Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 51: 274-82. PMID 19387354 DOI: 10.1097/Qai.0B013E3181A97Be5 |
0.543 |
|
| 2009 |
Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. The Journal of Infectious Diseases. 199: 926-35. PMID 19236279 DOI: 10.1086/597307 |
0.621 |
|
| 2009 |
Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. The Journal of Infectious Diseases. 199: 936-44. PMID 19236277 DOI: 10.1086/597309 |
0.622 |
|
| 2008 |
Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, GarcÃa P, Ault KA, Garland SM, Leodolter S, Olsson SE, et al. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine. 26: 6844-51. PMID 18930097 DOI: 10.1016/J.Vaccine.2008.09.073 |
0.559 |
|
| 2007 |
Smith JF, Brownlow M, Brown M, Kowalski R, Esser MT, Ruiz W, Barr E, Brown DR, Bryan JT. Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions. Human Vaccines. 3: 109-15. PMID 17611417 DOI: 10.4161/Hv.3.4.4058 |
0.636 |
|
| 2007 |
Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, Whalen CC, Salata RA. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. Journal of Medical Virology. 79: 758-65. PMID 17457908 DOI: 10.1002/Jmv.20817 |
0.62 |
|
| 2006 |
Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, Brown DR, Ferenczy A, Harper DM, Koutsky LA, Kurman RJ, Lehtinen M, Malm C, Olsson SE, Ronnett BM, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 24: 5571-83. PMID 16753240 DOI: 10.1016/J.Vaccine.2006.04.068 |
0.622 |
|
| 2006 |
Shew ML, Fortenberry JD, Tu W, Juliar BE, Batteiger BE, Qadadri B, Brown DR. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Archives of Pediatrics & Adolescent Medicine. 160: 151-6. PMID 16461870 DOI: 10.1001/Archpedi.160.2.151 |
0.582 |
|
| 2006 |
Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstetrics and Gynecology. 107: 18-27. PMID 16394035 DOI: 10.1097/01.Aog.0000192397.41191.Fb |
0.646 |
|
| 2006 |
Bryan JT, Taddeo F, Skulsky D, Jansen KU, Frain BM, Qadadri B, Brown DR. Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas. Journal of Medical Virology. 78: 117-24. PMID 16299730 DOI: 10.1002/Jmv.20512 |
0.642 |
|
| 2006 |
Brown DR, Kitchin D, Qadadri B, Neptune N, Batteiger T, Ermel A. The human papillomavirus type 11 E1--E4 protein is a transglutaminase 3 substrate and induces abnormalities of the cornified cell envelope. Virology. 345: 290-8. PMID 16257432 DOI: 10.1016/J.Virol.2005.09.048 |
0.445 |
|
| 2006 |
Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E. Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia Obstetrical & Gynecological Survey. 61: 315-316. DOI: 10.1097/01.Ogx.0000216516.16259.9B |
0.63 |
|
| 2005 |
Spartz H, Lehr E, Zhang B, Roman A, Brown DR. Progression from productive infection to integration and oncogenic transformation in human papillomavirus type 59-immortalized foreskin keratinocytes. Virology. 336: 11-25. PMID 15866067 DOI: 10.1016/J.Virol.2005.02.026 |
0.762 |
|
| 2005 |
Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. The Lancet. Oncology. 6: 271-8. PMID 15863374 DOI: 10.1016/S1470-2045(05)70101-7 |
0.528 |
|
| 2005 |
Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. The Journal of Infectious Diseases. 191: 182-92. PMID 15609227 DOI: 10.1086/426867 |
0.648 |
|
| 2004 |
Brown DR, Brown CR, Lehr EE. Intracellular expression patterns of the human papillomavirus type 59 E1/E4 protein in COS cells, keratinocytes, and genital epithelium. Intervirology. 47: 321-7. PMID 15564743 DOI: 10.1159/000080875 |
0.472 |
|
| 2004 |
Fife KH, Wheeler CM, Koutsky LA, Barr E, Brown DR, Schiff MA, Kiviat NB, Jansen KU, Barber H, Smith JF, Tadesse A, Giacoletti K, Smith PR, Suhr G, Johnson DA. Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women. Vaccine. 22: 2943-52. PMID 15246631 DOI: 10.1016/J.Vaccine.2003.11.058 |
0.621 |
|
| 2004 |
Brown DR, Fife KH, Wheeler CM, Koutsky LA, Lupinacci LM, Railkar R, Suhr G, Barr E, Dicello A, Li W, Smith JF, Tadesse A, Jansen KU. Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine. Vaccine. 22: 2936-42. PMID 15246630 DOI: 10.1016/J.Vaccine.2003.11.059 |
0.623 |
|
| 2004 |
Dillner J, Brown DR. Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine? Expert Reviews in Molecular Medicine. 6: 1-21. PMID 15096282 DOI: 10.1017/S1462399404007653 |
0.618 |
|
| 2004 |
Lehr E, Hohl D, Huber M, Brown D. Infection with Human Papillomavirus alters expression of the small proline rich proteins 2 and 3. Journal of Medical Virology. 72: 478-483. PMID 14748073 DOI: 10.1002/Jmv.20011 |
0.654 |
|
| 2003 |
Lehr EE, Qadadri B, Brown CR, Brown DR. Human papillomavirus type 59 immortalized keratinocytes express late viral proteins and infectious virus after calcium stimulation. Virology. 314: 562-71. PMID 14554084 |
0.531 |
|
| 2003 |
Lehr E, Brown DR. Infection with the oncogenic human papillomavirus type 59 alters protein components of the cornified cell envelope. Virology. 309: 53-60. PMID 12726726 |
0.597 |
|
| 2003 |
Fife KH, Coplan PM, Jansen KU, DiCello AC, Brown DR, Rojas C, Su L. Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men. Sexually Transmitted Diseases. 30: 246-8. PMID 12616145 DOI: 10.1097/00007435-200303000-00014 |
0.524 |
|
| 2003 |
Shew M, Tu W, Juliar B, Fortenberry D, Quaid B, Brown D. Factors associated with duration of genital HPV infection Journal of Adolescent Health. 32: 127. DOI: 10.1016/S1054-139X(02)00628-6 |
0.591 |
|
| 2002 |
Brown DR, Legge D, Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sexually Transmitted Diseases. 29: 763-8. PMID 12466717 DOI: 10.1097/00007435-200212000-00005 |
0.62 |
|
| 2002 |
Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. The New England Journal of Medicine. 347: 1645-51. PMID 12444178 DOI: 10.1056/Nejmoa020586 |
0.618 |
|
| 2002 |
Lehr E, Jarnik M, Brown DR. Human papillomavirus type 11 alters the transcription and expression of loricrin, the major cell envelope protein. Virology. 298: 240-7. PMID 12127787 |
0.579 |
|
| 2002 |
McClowry TL, Shors T, Brown DR. Expression of cytokeratin 16 in human papillomavirus type 11-infected genital epithelium. Journal of Medical Virology. 66: 96-101. PMID 11748664 DOI: 10.1002/Jmv.2116 |
0.594 |
|
| 2002 |
Shew ML, Fortenberry JD, Qadadri B, Brown D. Use of repeated, self-administered vaginal swabs for HPV detection in adolescent females Journal of Adolescent Health. 30: 98. DOI: 10.1016/S1054-139X(01)00357-3 |
0.515 |
|
| 2001 |
Bryan JT, Brown DR. Transmission of human papillomavirus type 11 infection by desquamated cornified cells Virology. 281: 35-42. PMID 11222093 DOI: 10.1006/viro.2000.0777 |
0.548 |
|
| 2000 |
Yeager MD, Aste-Amezaga M, Brown DR, Martin MM, Shah MJ, Cook JC, Christensen ND, Ackerson C, Lowe RS, Smith JF, Keller P, Jansen KU. Neutralization of human papillomavirus (HPV) pseudovirions: A novel and efficient approach to detect and characterize HPV neutralizing antibodies Virology. 278: 570-577. PMID 11118379 DOI: 10.1006/Viro.2000.0674 |
0.658 |
|
| 2000 |
Bryan JT, Tekchandani J, Schroeder JM, Brown DR. Propagation of Human Papillomavirus Type 59 in the Athymic Mouse Xenograft System Intervirology. 43: 112-118. PMID 10971130 DOI: 10.1159/000025033 |
0.654 |
|
| 2000 |
Bryan JT, Han A, Fife KH, Brown DR. The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium. Virology. 268: 430-9. PMID 10704351 DOI: 10.1006/Viro.1999.0173 |
0.4 |
|
| 1999 |
Kovelman R, Bilter GK, Roman A, Brown DR, Barbosa MS. Human papillomavirus type 6: classification of clinical isolates and functional analysis of E2 proteins. The Journal of General Virology. 80: 2445-2451. PMID 10501500 DOI: 10.1099/0022-1317-80-9-2445 |
0.636 |
|
| 1999 |
Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. Journal of Clinical Microbiology. 37: 3316-22. PMID 10488198 DOI: 10.1128/Jcm.37.10.3316-3322.1999 |
0.618 |
|
| 1999 |
Brown DR, McClowry TL, Woods K, Fife KH. Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus. Virology. 260: 165-72. PMID 10405368 DOI: 10.1006/Viro.1999.9822 |
0.657 |
|
| 1999 |
Fife KH, Katz BP, Brizendine EJ, Brown DR. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. American Journal of Obstetrics and Gynecology. 180: 1110-4. PMID 10329863 DOI: 10.1016/S0002-9378(99)70602-2 |
0.452 |
|
| 1998 |
Brown DR, McClowry TL, Bryan JT, Stoler M, Schroeder-Diedrich JM, Fife KH. A human papillomavirus related to human papillomavirus MM7/LVX82 produces distinct histological abnormalities in human foreskin implants grown as athymic mouse xenografts. Virology. 249: 150-9. PMID 9740786 DOI: 10.1006/Viro.1998.9294 |
0.653 |
|
| 1998 |
Brown DR, McClowry TL, Sidner RA, Fife KH, Bryan JT. Expression of the human papillomavirus type 11 E5A protein from the E1E4,E5 transcript. Intervirology. 41: 47-54. PMID 9705564 DOI: 10.1159/000024914 |
0.511 |
|
| 1998 |
Bryan JT, Fife KH, Brown DR. The intracellular expression pattern of the human papillomavirus type 11 E1--E4 protein correlates with its ability to self associate. Virology. 241: 49-60. PMID 9454716 DOI: 10.1006/Viro.1997.8965 |
0.342 |
|
| 1998 |
Bryan JT, Stoler MH, Tyring SK, McClowry T, Fife KH, Brown DR. High-grade dysplasia in genital warts from two patients infected with the human immunodeficiency virus. Journal of Medical Virology. 54: 69-73. PMID 9443111 DOI: 10.1002/(Sici)1096-9071(199801)54:1<69::Aid-Jmv10>3.0.Co;2-Z |
0.559 |
|
| 1997 |
Bryan JT, Jansen KU, Lowe RS, Fife KH, McClowry T, Glass D, Brown DR. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: Correlation with virus-like particle IgG concentration Journal of Medical Virology. 53: 185-188. PMID 9365880 DOI: 10.1002/(Sici)1096-9071(199711)53:3<185::Aid-Jmv1>3.0.Co;2-4 |
0.646 |
|
| 1997 |
Lowe RS, Brown DR, Bryan JT, Cook JC, George HA, Hofmann KJ, Hurni WM, Joyce JG, Lehman ED, Markus HZ, Neeper MP, Schultz LD, Shaw AR, Jansen KU. Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast. The Journal of Infectious Diseases. 176: 1141-5. PMID 9359711 DOI: 10.1086/514105 |
0.619 |
|
| 1997 |
Cramer HM, Skinner-Wannemuehler SE, Brown DR, Katz BP, Fife KH. Cytomorphologic correlates of human papillomavirus infection in the "normal" cervicovaginal smear. Acta Cytologica. 41: 261-8. PMID 9100752 DOI: 10.1159/000332452 |
0.607 |
|
| 1996 |
Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. American Journal of Obstetrics and Gynecology. 174: 1487-93. PMID 9065116 DOI: 10.1016/S0002-9378(96)70593-8 |
0.387 |
|
| 1996 |
Fife KH, Fan L, Fritsch MH, Bryan J, Brown DR. Association of human papillomavirus type 11 DNA with squamous cell carcinoma of the tongue. Archives of Otolaryngology--Head & Neck Surgery. 122: 1404-8. PMID 8956761 DOI: 10.1001/Archotol.1996.01890240110025 |
0.507 |
|
| 1996 |
Brown DR, Rawlings K, Handy V, Fife KH, Bryan JT, Cramer H, Graham M. Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens Journal of Medical Virology. 48: 210-214. PMID 8835357 DOI: 10.1002/(Sici)1096-9071(199602)48:2<210::Aid-Jmv15>3.0.Co;2-I |
0.656 |
|
| 1996 |
Hofmann KJ, Neeper MP, Markus HZ, Brown DR, Müller M, Jansen KU. Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae Journal of General Virology. 77: 465-468. PMID 8601783 DOI: 10.1099/0022-1317-77-3-465 |
0.624 |
|
| 1996 |
Brown DR, Pratt L, Bryan JT, Fife KH, Jansen K. Virus-like Particles and E1AE4 Protein Expressed from the Human Papillomavirus Type 11 Bicistronic E1AE4AL1 Transcript Virology. 222: 43-50. DOI: 10.1006/Viro.1996.0396 |
0.4 |
|
| 1995 |
Brown DR, Bryan JT, Pratt L, Handy V, Fife KH, Stoler MH. Human papillomavirus type 11 E1--E4 and L1 proteins colocalize in the mouse xenograft system at multiple time points. Virology. 214: 259-63. PMID 8525625 DOI: 10.1006/Viro.1995.9931 |
0.488 |
|
| 1995 |
Roman A, Brown D. Sequence variation in the extreme 5’ end of the human papillomavirus type 6a long control region Journal of Infectious Diseases. 171: 697-700. PMID 7876621 DOI: 10.1093/Infdis/171.3.697 |
0.515 |
|
| 1995 |
Hofmann KJ, Cook JC, Joyce JG, Brown DR, Schultz LD, George HA, Rosolowsky M, Fife KH, Jansen KU. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology. 209: 506-18. PMID 7778283 DOI: 10.1006/Viro.1995.1283 |
0.309 |
|
| 1994 |
Wools K, Bryan JT, Katz BP, Rodriguez M, Davis T, Brown DR. Detection of human papillomavirus L1 protein in condylomata acuminata from various anatomical sites. Sexually Transmitted Diseases. 21: 103-6. PMID 9071421 DOI: 10.1097/00007435-199403000-00009 |
0.566 |
|
| 1994 |
Brown DR, Fan L, Jones J, Bryan J. Colocalization of Human Papillomavirus Type 11 E1^E4 and L1 Proteins in Human Foreskin Implants Grown in Athymic Mice Virology. 201: 46-54. PMID 8178488 DOI: 10.1006/Viro.1994.1264 |
0.559 |
|
| 1994 |
Brown DR, Bryan JT, Cramer H, Katz BP, Handy V, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients. The Journal of Infectious Diseases. 170: 759-65. PMID 7930715 DOI: 10.1093/Infdis/170.4.759 |
0.636 |
|
| 1993 |
Brown DR, Bryan JT, Cramer H, Fife KH. Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques. Journal of Clinical Microbiology. 31: 2667-73. PMID 8253963 DOI: 10.1128/Jcm.31.10.2667-2673.1993 |
0.612 |
|
| 1992 |
Brown DR, Bryan JT, Rodriguez M, Katz BP. Factors associated with detection of human papillomavirus E4 and L1 proteins in condylomata acuminata. The Journal of Infectious Diseases. 166: 512-7. PMID 1323617 DOI: 10.1093/Infdis/166.3.512 |
0.54 |
|
| 1991 |
Brown DR, Bryan J, Rodriguez M, Rose RC, Strike DG. Detection of human papillomavirus types 6 and 11 E4 gene products in condylomata acuminatum. Journal of Medical Virology. 34: 20-8. PMID 1653305 DOI: 10.1002/Jmv.1890340105 |
0.616 |
|
| 1990 |
Brown DR, Fife KH. Human papillomavirus infections of the genital tract. The Medical Clinics of North America. 74: 1455-85. PMID 2174093 DOI: 10.1016/S0025-7125(16)30490-4 |
0.628 |
|
| Show low-probability matches. |